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Segmental duplications, which comprise ~5%–10% of the human genome, are known to mediate medically relevant deletions,
duplications, and inversions through nonallelic homologous recombination (NAHR) and have been suggested to be hot spots in
chromosome evolution and human genomic instability. We report seven individuals with microdeletions at 17q23.1q23.2, identiﬁed
by microarray-based comparative genomic hybridization (aCGH). Six of the seven deletions are ~2.2 Mb in size and ﬂanked by large
segmental duplications of >98% sequence identity and in the same orientation. One of the deletions is ~2.8 Mb in size and is ﬂanked
on the distal side by a segmental duplication, whereas the proximal breakpoint falls between segmental duplications. These character-
istics suggest that NAHRmediated six out of seven of these rearrangements. These individuals have common features, includingmild to
moderate developmental delay (particularly speech delay), microcephaly, postnatal growth retardation, heart defects, and hand, foot,
and limb abnormalities. Although all individuals had at least mild dysmorphic facial features, there was no characteristic constellation
of features that would elicit clinical suspicion of a speciﬁc disorder. The identiﬁcation of common clinical features suggests that micro-
deletions at 17q23.1q23.2 constitute a novel syndrome. Furthermore, the inclusion in the minimal deletion region of TBX2 and TBX4,
transcription factors belonging to a family of genes implicated in a variety of developmental pathways including those of heart and limb,
suggests that these genes may play an important role in the phenotype of this emerging syndrome.Segmental duplications comprise ~5%–10% of the human
genome.1 Misalignment of segmental duplications during
meiosis can mediate genomic instability by nonallelic
homologous recombination (NAHR). Depending on the
orientation of the segmental duplications, NAHR can
generate microdeletions, microduplications, and inver-
sions of the intervening genomic sequence.2–7 Chromo-
somal rearrangements associated with segmental duplica-
tions include microdeletions at 3q29 (MIM 609425)
and their reciprocal microduplications (MIM 611936);8
Williams syndrome (MIM 194050) and deletions at
7q11.23; Angelman (MIM 105830) and Prader-Willi syn-
dromes (MIM 176270) and maternally and paternally
derived deletions, respectively, of 15q11-q13; microdele-
tions at 16p11.2p12.2 and their reciprocal microduplica-
tions;9 Smith-Magenis syndrome (MIM 182290) and
deletions at 17p11.2; duplication at 17p12 in Charcot-
Marie-Tooth disease type 1A (MIM 604563); and the recip-
rocal deletion at 17p12 resulting in hereditary neuropathy
with liability to pressure palsies (HNPP [MIM 162500])1Signature Genomic Laboratories, Spokane, WA 99207, USA; 2Department of La
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454 The American Journal of Human Genetics 86, 454–461, March 1(reviewed in 4). Recently, a recurrent microdeletion at
17q21.3 mediated by segmental duplications was identi-
ﬁed by screening individuals with idiopathic mental
retardation and congenital anomalies with a microarray
targeting potential segmental duplication-rich rearrange-
ment ‘‘hot spots’’ in the genome,5–7 suggesting that other
such rearrangements may yet be identiﬁed.
Recent evidence suggests another segmental duplication
‘‘hub’’ on chromosome 17 at 17q23. Breakpoint analysis of
a paracentric inversion that occurred in the human/chim-
panzee/gorilla ancestor revealed that the distal breakpoint
maps to the region syntenic to human 17q23, which
suggests that the presence of this duplicon mediated the
inversion in the Homo sapiens/Pan troglodytes/Gorilla gorilla
ancestor.10 Furthermore, at least two insertions and dele-
tions and one translocation have occurred within the
past six million years since the divergence of chimpanzees
and humans, indicating that these regions have continued
to be subject to more-recent local rearrangements. Further
data have demonstrated the structural complexity of theboratory Medicine, Nationwide Children’s Hospital, Columbus, OH 43209,
209, USA; 4Department of Pediatrics, The Ohio State University, Columbus,
mbus, OH 43209, USA; 6Center for Molecular and Human Genetics, The
SA; 7Department of Pediatrics, Maine Pediatric Specialty Group, Portland,
Durham, NC 27710, USA; 9Weisskopf Child Evaluation Center, University
ory University School of Medicine, Atlanta, GA 30322, USA; 11Department
SA; 12Division of Genetics and Genomic Medicine, Vanderbilt University
olecular Genetics, Baylor College of Medicine, Houston, TX 77030, USA;
rsaw, Poland
Genetics. All rights reserved.
2, 2010
A B
17q22 17q23.1 17q23.2
55 Mb 56 Mb 57 Mb 58 Mb
~2.2 Mb 
~2.8 Mb 
T
B
X
2
 
T
B
X
4
 
C
A
4
  
U
S
P
3
2
 
A
P
P
B
P
2
 
B
C
A
S
3
 
N
A
C
A
2
  
B
R
IP
1
 
IN
T
S
2
 
P
P
M
1
D
 
M
E
D
1
3
 
T
L
K
2
  
Y
P
E
L
2
  
D
H
X
4
0
  
C
L
T
C
  
T
M
E
M
4
9
 
 
P
T
R
H
2
  
T
U
B
D
1
  
R
P
S
6
K
B
1
  
T
E
X
1
4
  
R
A
D
5
1
C
  
T
R
IM
3
7
 
M
R
C
2
  
Patient 1
Patient 2
Patient 3
Patient 4
Patient 5
Patient 6
Seg Dups
Patient 7
A B
Figure 1. Summary of Microarray Anal-
ysis of Individuals with Copy Number
Imbalances at 17q23.1q23.2
At the top of the ﬁgure is a partial idiogram
showing chromosome bands 17q22-
17q23.2 with genomic coordinates corre-
sponding to the hg18 build of the human
genome. Orange boxes represent seg-
mental duplications (seg dups), with paired
segmental duplications indicated by blue
boxes. The location and orientation of
the 18 kb inverted duplication and the
15 kb direct duplication contained within
the paired segmental duplications are indi-
cated by arrows marked A and B, respec-
tively. The complex segmental duplication
structure of this region has been simpliﬁed
for illustrative purposes. Diagrams show
the deletions in seven individuals with mi-
crodeletions at 17q23.1q23.2. Six of the
seven deletions were reﬁned with a high-
density, 244K oligonucleotide microarray
(patients 1–4, 6, and 7). A 105K oligonucle-
otide microarray was used for patient 5.
Vertical dashed lines indicate the 2.2 and
2.8 Mb deletion sizes in the individuals.
Blue boxes represent all known genes
annotated in OMIM in the deletion region.
OMIM genes TBX2 and TBX4 are shown as
yellow boxes.region, which has been shown to be polymorphic in the
human population and associated with a multiple sclerosis
susceptibility locus on 17q22-q24.11,12
Here we report the clinical and molecular characteriza-
tion of seven individuals with microdeletions at 17q23.
1q23.2. Patients 1–3 in this study were ascertained by Sig-
nature Genomic Laboratories. Patients 4 and 5 were
ascertained by Nationwide Children’s Hospital. Patient
6 was ascertained by Emory University School of Medicine.
Patient 7 was ascertained by Baylor College of Medicine.
Informed consent was obtained from patients 1, 4, 6, and
7 to publish photographs with consent forms approved
by the Institutional ReviewBoard of respective institutions.
All seven individuals with microdeletions at 17q23 were
initially identiﬁed by microarray-based comparative
genomic hybridization (aCGH) with various microarray
platforms, one of which, patient 6, was previously reported
(Figure 1).13Whole-genomebacterial artiﬁcial chromosomeThe American Journal of Human G(BAC)-based microarray analysis was
originally performed on DNA from
patients 1 and 2 with a >4600 clone
custom microarray as previously
described.14 Oligonucleotide-based
microarray analysis was originally
performed on DNA from patients 3–5
with a custom 105K-feature whole-
genomemicroarray (Agilent Technolo-
gies), as previously described.14 The
deletion in patient 6 was identiﬁed
with a custom 44K oligonucleotide-based microarray (Agilent Technologies), as previously
described.13,15 The deletion in patient 7was originally iden-
tiﬁed with a custom-designed 105K-feature whole-genome
oligonucleotidemicroarray (Agilent Technologies), as previ-
ously described.16 In addition, all patients for whom DNA
was available (1–4, 6, and 7) were reanalyzed at higher
resolution with an off-the-shelf 244K-feature whole-
genome microarray (Agilent Technologies), as previously
described.14One individual, patient2,hada2.8Mbdeletion
(chromosome17: 54.8–57.6Mb); the remaining six individ-
uals had 2.2Mb deletions (chromosome 17: 55.4–57.6Mb).
All seven deletions were conﬁrmed and visualized by
ﬂuorescence in situ hybridization (FISH) with BAC clones,
as previously described (Figure 2).17 Parental FISH testing
in ﬁve of the seven cases conﬁrmed an apparently de
novo origin (patients 2 and 4–7). The deletions in patients
1–3 and 5 were conﬁrmed by FISH with BAC probe RP11-
289K16 from 17q23.1. For case 4, BAC RP11-119J7 wasenetics 86, 454–461, March 12, 2010 455
Figure 2. Representative FISH Image Showing Deletion at
17q23 in Patient 2
BAC clone RP11-289K16 from 17q23.1 is labeled in red, and chro-
mosome 17 centromere probe D17Z1 is labeled in green as
a control. The absence of a red signal on one homolog (arrow)
indicates deletion at 17q23.1.used to conﬁrm the deletion. The deletion in patient 6 was
conﬁrmed by FISH with BAC RP11-436E15, as previously
described,13,15 and the deletion in patient 7 was conﬁrmed
by FISH with BAC clone RP11-615P24. Microsatellite
marker analysis with the Identiﬁler kit (Applied Biosys-
tems) showed correct paternity in patient 6, conﬁrming
the de novo origin of the deletion (Rudd et al.13). All other
parental samples were unavailable.
Computational analysis of the 17q23.1q23.2 region
with the hg18 build of the UCSC genome browser18 and
the hg17 build of the Human Genome Segmental Duplica-
tion Database identiﬁed a complex arrangement of
segmental duplications, some of which directly ﬂank the
2.2 Mb deletion breakpoints and the distal 2.8 Mb break-
point (Figure 1). These ﬂanking segmental duplications
are ~100 kb in size and have a complex evolutionary struc-
ture10 that includes an ~15 kb segment of >98% sequence
identity present in the same orientation. In addition, there
is an ~18 kb segment of >94% sequence identity that is
inverted in orientation with respect to its duplication
partner. The 2.2 Mb deletions are ﬂanked by the homolo-
gous segmental duplications present in the same orienta-
tion. Highly identical (>98% sequence identity) segmental
duplications in direct orientation ﬂanking the deletion
breakpoints are consistent with NAHR-mediated rear-
rangements (Figure 1). Although six of seven deletions
were ﬂanked by segmental duplications, the proximal
breakpoint of the 2.8 Mb deletion falls between two
segmental duplications (Figure 1). Atypical breakpoints
have been reported for other recurrent rearrangements
mediated by segmental duplications: for example, some
of the rarer rearrangements of 17p11.2 associated with
Smith-Magenis syndrome do not have breakpoints ﬂanked
by the typical paired segmental duplications and are not
associated with known genomic architectural features,19
and some of the breakpoints in the recently identiﬁed
16p11.2p12.2 microdeletion syndrome are not ﬂanked
by segmental duplications.9
Clinical characterization of the seven individuals with
microdeletions at 17q23.1q23.2 revealed multiple com-
mon clinical features (Table 1; see also Supplemental456 The American Journal of Human Genetics 86, 454–461, March 1Discussion available online). All individuals had mild to
moderate developmental delay. A majority had low birth
weight (5 of 7); microcephaly or relative microcephaly
(5 of 7), including one with overall small growth parame-
ters; postnatal growth retardation (5 of 7); heart defect(s)
(6 of 7), in most cases either patent ductus arteriosus or
atrial septal defect (ASD); hand and foot anomalies
including long, thin ﬁngers and toes (7 of 7); andmusculo-
skeletal abnormalities of varying severity (4 of 7). Features
identiﬁed in more than one individual include aggressive
behavior (2 of 7) and hearing loss (2 of 7). Although ﬁve
of seven individuals had eye anomalies such as chalazion,
stellate pattern of the irises, retinopathy of prematurity,
and esotropia, the anomalies affect different components
of the eye and are unlikely to be related; therefore, these
anomalies are likely incidental to the 17q23.1q23.2 micro-
deletion phenotype. Although all individuals had at least
mild dysmorphic facial features, there was no character-
istic constellation of features that would elicit clinical
suspicion of a speciﬁc disorder (Figure 3). Nonetheless,
the common clinical features in these individuals together
with the common size and gene content of the deleted
regions suggest that deletion at 17q23.1q23.2 is causative
of the individuals’ phenotypes and may constitute a novel
microdeletion syndrome.
From November 2007 to October 2009, Signature
Genomic Laboratories tested 19,912 patients with whole-
genome microarray platforms that had coverage over
17q23.1q23.2 and identiﬁed three microdeletions of
17q23.1q23.2, for a frequency of 0.015% among its patient
population. By comparison, during this same period, the
laboratory identiﬁed 23 Smith-Magenis syndrome (SMS)
deletions (0.12% of patient population), which has a
frequency in the general population of ~1 in 15,000,20 sug-
gesting that the population frequency of 17q23.1q23.2
microdeletions may be ~1 in 115,000. This may be an over-
estimate of frequency because some cases of SMS are diag-
nosed by other methods, and therefore not all individuals
with these syndromes will have aCGH testing, whereas
17q23.1q23.2 microdeletions would not be expected to
be diagnosed by other methods that require clinical suspi-
cion of a speciﬁc disorder.
Because the phenotype of the individual with the larger
2.8 Mb deletion does not appear to differ from that of the
individuals with the smaller 2.2 Mb deletion, the critical
region for this syndrome likely lies inside this 2.2 Mb
region. Of the 11 OMIM and RefSeq genes within the 2.2
Mb smallest region of overlap (Figure 1), at least two,
TBX2 (MIM 600747) and TBX4 (MIM 601719), are strong
candidates that might play a role in some of the features
of individuals with this microdeletion.
TBX2 and TBX4 belong to an ancient family of genes
present in divergent multicellular organisms, such as
sponges and humans, that encode transcription factors
characterized by a strongly conserved, sequence-speciﬁc
DNA-binding domain (or T-box domain). More speciﬁ-
cally, TBX2 and TBX4 are members of two closely related2, 2010
Table 1. Clinical Features in Subjects with Microdeletions at 17q23.2
Patient Number 1 2a 3 4 5 6 7
Age 3 yrs 5 yrs, 1 mo. 4 yrs 16 yrs, 6 mo. 8 mo. 4 yrs 1 yr, 10 mo.
Sex Female Female Male Female Female Female Female
Low birth weight
(%25th percentile)
þ þ  þ þ þ 
Postnatal growth
retardation
þ   þ þ þ þ
Microcephaly
(<5th percentile)
þ þ þ (relative)  þb  þ
Mild to moderate
developmental
delays
þ þ þ þ þ þ þ
Heart defects PDA ASD secundum Pulmonary
hypertension
PDA with
pulmonary
hypertension
PDA; bicuspid
aortic valve
None; no
echocardiography
ASD secundum
with pulmonary
hypertension
Musculoskeletal Tibial torsion Abnormally
laterally
positioned
ossiﬁcation
centers of the
patella, delayed
for age
Underossiﬁed
femoral heads;
hips deeply seated
in acetabulae;
mottled femoral
epiphyses and
metaphyses; small
and abnormal
lower-limb
epiphyses
Short stature
with leg length
discrepancy;
hypoplasia of
patellae and tibial
epiphyses; shallow
acetabulae; right
side short femoral
neck with coxa
vara and magna;
scoliosis
NR None Scoliosis; limited
extension of
knees and
elbows
Hearing loss þ   þ   
Eyes Chalazion Left sided
esotropia
Normal Bilateral
esotropia
Retinopathy
of prematurity
Stellate pattern
of irises
Normal
Facial features High eyebrows;
right epicanthal
fold
Hypertelorism;
ﬂattened nasal
bridge and
midface; simple
right ear
Plagiocephaly;
bilateral inner
epicanthal folds;
bulbous, biﬁd
nose; posteriorly
rotated,
prominent ears;
long eyelashes
Prominence
of forehead;
moderate dental
crowding
requiring
orthodontic
appliances
Box-shaped
cranium; open
anterior
fontanelle;
prominent
forehead; wide-set
eyes, small nose
with bulbous nasal
tip; microstomia;
small ears;
recessed jaw
Mild frontal
bossing; rounded
nasal tip; wide
space between
front two teeth
Mild
micrognathia;
long eyelashes;
protuberant ears;
small mouth;
long neck
Hands and feet Thin ﬁngers; deep,
grooved space
between ﬁrst
and second toes;
familial 2–3
syndactyly
Long, thin
ﬁngers and
toes
Long, thin ﬁngers
and toes; second
toes longer than
great toes
Long, thin ﬁngers
and toes; digital
clubbing; bilateral
pes planus;
slightly shortened
foot rays
Long ﬁngers
and toes
Long ﬁngers
and toes;
overlapping toes
Congenital
contractures; long
ﬁngers and toes;
overlapping toes 4
and 5; pes planus;
ﬁfth ﬁnger
clinodactyly
Other Behavioral
abnormalities;
intention tremors;
asthma
NR Tethered cord;
sacral dimples;
shawl scrotum
Mild increased
DTR at knees and
ankles; migraines
Cutis aplasia at
birth; central
hypotonia;
brisk DTRs
Behavioral
abnormalities
NR
The following abbreviations are used: þ, feature present; , feature absent; PDA, patent ductus arteriosus; ASD, atrial septal defect; DTR, deep tendon reflexes;
NR, none reported.
a Patient 2 has an atypical ~2.8 Mb deletion. All other patients described in this table have ~2.2 Mb deletions.
b All growth parameters were at the fifth percentile.T-box subfamilies, TBX2/3 and TBX4/5. Interestingly, at
least 17 evolutionary rearrangements, including gene
cluster insertions and deletions, one inversion, and one
local translocation, have occurred within the region since
the divergence of humans and chickens ~300million years
ago. Despite the instability of the region in which the geneThe Ameripair resides, TBX2 and TBX4 (as well as TBX3 and TBX5)
have remained ﬂanked by several loci present in all
amniotes, BCAS33 and BRIP1 (MIM 605822) (THRAP2
[MIM 608711] and RBM19 ﬂank TBX3 [MIM 601621]
and TBX5 [MIM 601620]).21 The high conservation of
these gene clusters indicates a functional signiﬁcance.can Journal of Human Genetics 86, 454–461, March 12, 2010 457
Figure 3. Facial Features of Individuals with Microdeletion at
17q23.1q23.2
(A) Patient 1 at 3 years. Note high eyebrows and right epicanthal
fold.
(B) Patient 6 at 4 years. Note mild frontal bossing and rounded
nasal tip.
(C and D) Patient 7 at 22 months. Note long eyelashes, protu-
berant ears, small mouth, and mild micrognathia.
(E and F) Patient 4 at 16 years. With the exception of some
prominence of the forehead, this patient was not noted to be
dysmorphic.Alternatively, the presence of large segmental duplications
in the region of 17q23 may predispose the region to rear-
rangements that conserve the linkage of these genomic
segments.
Targeted gene deletions in mouse have demonstrated
that T-box genes play numerous roles in development;
consequently, disruptions of many of these genes have
been associated with human disease. Mutations in the
coding sequence of TBX1 (MIM 602054), which maps
within the DiGeorge syndrome (DGS) region (MIM
188400) on chromosome 22q11.2,22 have been identiﬁed
in individuals with sporadic DGS/conotruncal anomaly
face syndrome/velocardiofacial syndrome (VCFS),23–25
which has a characteristic clinical feature of outﬂow tract
heart defects. In addition, heterozygous mutations in
TBX3 cause ulnar-mammary syndrome (UMS [MIM
181450]),26,27 which has a characteristic feature of poste-
rior upper-limb abnormalities; heterozygous loss-of-
function mutations of TBX4 in 15 individuals from ﬁve
families and one sporadic patient were found to cause458 The American Journal of Human Genetics 86, 454–461, March 1the autosomal-dominant Scott-Taor or small patella
syndrome (SPS [MIM 147891]);28 heterozygous mutations
in TBX5 cause anterior limb abnormalities and ASD in
Holt-Oram syndrome (MIM 142900);27 and mutations of
TBX20 (MIM 606061) have been associated with congen-
ital heart disease and cardiac developmental anomalies,
including defects in septation, chamber growth, and
valvulogenesis and cardiomyopathy.29
The TBX2/3 and TBX4/5 subfamilies of genes are espe-
cially interesting as haploinsufﬁciency candidates in mi-
crodeletions at 17q23 because of their role in the evolution
of novel vertebrate structures, including mouse limbs.30
Tbx2 is expressed in the anterior and posterior margins
of forelimbs and hindlimbs,31–33 and loss-of function and
misexpression studies suggest a role for Tbx2 in the antero-
posterior patterning of digits.34 All individuals reported
here had long ﬁngers and toes, and some had additional
digital anomalies (Table 1); patient 4, for example, had
slightly shortened fourth and ﬁfth rays of both feet
(Figure 4). The presence of subtle digital anomalies in indi-
viduals with microdeletions at 17q23.1q23.2 suggests that
haploinsufﬁciency of TBX2 plays a role in the phenotype.
Expression studies in chicken and mice show limb-
speciﬁc expression of Tbx4 in forelimbs and hindlimbs,
which suggests that Tbx4 plays a role in lower-limb devel-
opment.32,35–37 Although recent studies in mice have sug-
gested that Tbx4 expression does not confer limb-speciﬁc
morphology to the limb that subsequently develops,38,39
it is clear that the gene plays a vital role in themaintenance
of limb outgrowth.
The association between mutations of TBX4 and SPS
further suggests that the gene plays a role in the musculo-
skeletal phenotypes of the patients reported here. SPS is
better characterized as ischiopatellar dysplasia because
clinical diagnosis includes essential features in addition
to patellar aplasia or hypoplasia.40 These essential addi-
tional features are absent, delayed, or irregular ossiﬁcation
of the ischiopubic junctions and/or the infra-acetabular
axe-cut notches.28 Individuals with SPS and known TBX4
mutations may also have femur and foot anomalies.28 In
contrast, some sporadic cases reported that predate TBX4
mutation analysis had, in addition to dysplasia of the
lower limbs and pelvis, dysmorphic facial features and
digital anomalies.40–43 Thus, these sporadic cases may
have TBX4mutations or, based on the features in addition
to essential SPS features, may actually represent deletions
at 17q23.1q23.2. Likewise, the musculoskeletal abnormal-
ities identiﬁed in patients 3 and 4 of this study are reminis-
cent of, but not speciﬁc to, SPS (Figure 5). For example,
patient 4 has lower limb abnormalities similar to patients
with TBX4 mutations28 including small patellae, infra-
acetabular axe-cut notches, abnormal femoral heads, lesser
trochanter hypoplasia, and pes planus. In contrast, patient
4 has shortened rather than elongated femoral neck and
no ischiopubic ossiﬁcation abnormality. It is unknown
whether the absence of SPS-likemusculoskeletal abnormal-
ities in the other individuals in this study is because2, 2010
Figure 4. Hand and Foot Abnormalities
in Individuals with Microdeletion at
17q23.1q23.2
(A) Feet of patient 1. In this individual, 2–3
syndactyly is familial and likely indepen-
dent of this syndrome.
(B andC) Right foot andhands of patient 4.
Note the long, thin ﬁngers and toes, with
the second toe longer than the great toe.
(D) X-rays of feet of patient 3. The second
digit of both feet is elongated compared to
the great toe, and multiple bipartite
growth plates are seen throughout the
metatarsal heads.
(E) X-rays of feet of patient 4. There is
slight shortening of the fourth and ﬁfth
rays bilaterally.detailed skeletal surveys were not performed, although
patient 6 was speciﬁcally noted to lack any patellar, pelvic,
or foot anomalies characteristic of SPS.13 Therefore, dele-
tions of TBX4 may show incomplete penetrance for SPS.
Concerning the dysmorphic features, there does not
seem to be a common constellation of features among
the SPS patients in the literature and our patients,
although this does not rule out the possibility of the
previously reported sporadic cases being deletions at
17q23.1q23.2.not completely covered by the acetabulum, with the lateral third uncovered. There is mini
head is approximately 15% uncovered by the bony acetabulum. The femoral head is norm
the infra-acetabulae (arrows).
The American Journal of Human GInterestingly, it has been suggested
that an ancestral function of Tbx4/
Tbx5 in chordates involved heart cell
speciﬁcation and that, during the
evolution of vertebrates, the geneswere co-opted to play a role in the initiation of limb
outgrowth.21 Furthermore, studies of Tbx2 in the devel-
oping mouse heart show that Tbx2 is expressed in areas
complementary to that of Anf, expression of which is
speciﬁc to formation of the ventricular and atrial cham-
bers; Tbx2 also cooperatively functions with Nkx2.5 on
the Anf promoter to repress Anf activity.44 The presence
of ‘‘heart-hand’’ syndromes in human, including Holt-
Oram syndrome, the characteristic features of which are
thumb anomalies and ASD, provide further evidence thatFigure 5. X-rays Showing Musculoskel-
etal Findings Reminiscent of Mutations
of TBX4 and Small Patella Syndrome
(A–C) Patellar X-rays for patient 2. Note
abnormally laterally positioned ossiﬁca-
tion centers of the patella, which is de-
layed for age. The patella is normally
located on the sunrise view, suggesting
intermittent subluxation.
(D–F) X-rays for patient 4.
(D) There is lateral subluxation of the
patella bilaterally. The patellae are small.
The medial tibial plateau is mildly hypo-
plastic, with mild relative overgrowth of
the femoral condyle medially.
(E) The lateral portion of the distal tibial
epiphysis is hypoplastic bilaterally. There
is a tilting of the talar dome.
(F) The anteroposterior pelvis shows
mildly shallow right acetabulum with
slight widening of the supra-acetabular
iliac bone. There is coxamagna and a short
femoral neck on the right with varus
deformity, with the greater trochanter
slightly higher than the superior right
femoral head. The right femoral head is
mal superior subluxation. The left femoral
al in contour. There are axe-cut notches of
enetics 86, 454–461, March 12, 2010 459
T-box genes play dual roles in limb outgrowth and heart
speciﬁcation. Such a mechanism may also explain the
presence of heart and limb anomalies in individuals with
microdeletions at 17q23.1q23.2.
We have identiﬁed a previously unknownmicrodeletion
syndrome at 17q23.1q23.2 by analyzing individuals with
mental retardation, developmental delay, or dysmorphic
features by array CGH. The common clinical features of
these individuals and the presence of segmental duplica-
tions ﬂanking the deletion breakpoints suggest that
deletions at 17q23.1q23.2 represent a novel recurrent mi-
crodeletion. The identiﬁcation of additional cases with
microdeletions at 17q23.1q23.2 should further elucidate
the clinical features of this emerging syndrome.
Supplemental Data
Supplemental Data include Supplemental Discussion and can be
found with this article online at http://www.ajhg.org.
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